Search

everythinglearnresearchcommunity

for

Search:↓

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Hydroxychloroquine may help treat alopecia areata in children.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Low vitamin D levels are common in people with Alopecia Areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Apremilast shows promise for several skin conditions but needs more research.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Oxidative stress is linked to mild patchy alopecia areata.